Stock Track | SBP GROUP Plummets 5.35% Intraday as Pharmaceutical Sector Faces Broad Selling Pressure

Stock Track07-30

SBP GROUP (01177) shares plummeted 5.35% during intraday trading on Thursday, reflecting a sharp sell-off amid a broader downturn in the pharmaceutical sector.

The decline came as the entire pharmaceutical sector faced heavy selling pressure, with peers such as CSPC Pharma, ASYMCHEM, HANSOH Pharma, and HENGRUI Pharma also trading lower. Additionally, Nomura recently trimmed its target price for SBP GROUP from HK$8.67 to HK$8.26, which may have contributed to the negative sentiment, although the consensus analyst mean target remains well above current levels.

Despite recent positive developments, including a joint venture with Indonesia's Tempo Scan and clinical trial approval for a hepatitis B drug, the stock succumbed to the sector-wide headwinds.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1101575490?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 11:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101575490","market":"hk","top_or_hot":-1,"title":"Stock Track | SBP GROUP Plummets 5.35% Intraday as Pharmaceutical Sector Faces Broad Selling Pressure","media":"Stock Track","content":"<p>SBP GROUP (01177) shares plummeted 5.35% during intraday trading on Thursday, reflecting a sharp sell-off amid a broader downturn in the pharmaceutical sector.</p><p>The decline came as the entire pharmaceutical sector faced heavy selling pressure, with peers such as CSPC Pharma, ASYMCHEM, HANSOH Pharma, and HENGRUI Pharma also trading lower. Additionally, Nomura recently trimmed its target price for SBP GROUP from HK$8.67 to HK$8.26, which may have contributed to the negative sentiment, although the consensus analyst mean target remains well above current levels.</p><p>Despite recent positive developments, including a joint venture with Indonesia's Tempo Scan and clinical trial approval for a hepatitis B drug, the stock succumbed to the sector-wide headwinds.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | SBP GROUP Plummets 5.35% Intraday as Pharmaceutical Sector Faces Broad Selling Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | SBP GROUP Plummets 5.35% Intraday as Pharmaceutical Sector Faces Broad Selling Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-30 11:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SBP GROUP (01177) shares plummeted 5.35% during intraday trading on Thursday, reflecting a sharp sell-off amid a broader downturn in the pharmaceutical sector.</p><p>The decline came as the entire pharmaceutical sector faced heavy selling pressure, with peers such as CSPC Pharma, ASYMCHEM, HANSOH Pharma, and HENGRUI Pharma also trading lower. Additionally, Nomura recently trimmed its target price for SBP GROUP from HK$8.67 to HK$8.26, which may have contributed to the negative sentiment, although the consensus analyst mean target remains well above current levels.</p><p>Despite recent positive developments, including a joint venture with Indonesia's Tempo Scan and clinical trial approval for a hepatitis B drug, the stock succumbed to the sector-wide headwinds.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01177","symbol_name":"中国生物制药","start_time":0,"source_url":"","article_id":"1101575490","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101575490","pubTimestamp":1785381781,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"SBP GROUP (01177) shares plummeted 5.35% during intraday trading on Thursday, reflecting a sharp sell-off amid a broader downturn in the pharmaceutical sector.The decline came as the entire...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01177":"中国生物制药"},"translate_title":"股票跟踪 | 制药板块面临广泛抛售压力，SBP GROUP 盘中暴跌 5.35%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"SBP GROUP (01177) shares plummeted 5.35% during intraday trading on Thursday, reflecting a sharp sell-off amid a broader downturn in the pharmaceutical sector.The decline came as the entire pharmaceutical sector faced heavy selling pressure, with peers such as CSPC Pharma, ASYMCHEM, HANSOH Pharma, and HENGRUI Pharma also trading lower. Additionally, Nomura recently trimmed its target price for SBP GROUP from HK$8.67 to HK$8.26, which may have contributed to the negative sentiment, although the consensus analyst mean target remains well above current levels.Despite recent positive developments, including a joint venture with Indonesia's Tempo Scan and clinical trial approval for a hepatitis B drug, the stock succumbed to the sector-wide headwinds.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1101575490","isCrawlerRequest":true}